Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson's disease.
Hidetomo MurakamiTakahiko TokudaOmar M A El-AgnafTakuma OhmichiAyako MikiHideaki OhashiYoshiyuki OwanYu SaitoSatoshi YanoTamao TsukieTakeshi IkeuchiKenjiro OnoPublished in: BMC neurology (2019)
CSF levels of αS are correlated with some clinical symptoms and CSF levels of other pathogenic proteins in drug-naïve PD patients. These correlations suggest a central role for interaction and aggregation of αS with Aβ1-42, tau, and phosphorylated tau in the pathogenesis of PD. Although O-αS has been shown to have neurotoxic effects, CSF levels do not reflect clinical symptoms or levels of other proteins in cross-sectional assessment.